[go: up one dir, main page]

MA26862A1 - Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate - Google Patents

Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate

Info

Publication number
MA26862A1
MA26862A1 MA26710A MA26710A MA26862A1 MA 26862 A1 MA26862 A1 MA 26862A1 MA 26710 A MA26710 A MA 26710A MA 26710 A MA26710 A MA 26710A MA 26862 A1 MA26862 A1 MA 26862A1
Authority
MA
Morocco
Prior art keywords
hydroxycyclohexyl
esters derived
phennyl
dimethylaminomethyl
hydroxybenzoate
Prior art date
Application number
MA26710A
Other languages
English (en)
Inventor
Mancini Marisabel Mourelle
Ramon Amat Elisabet De
Clotet Huguet
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of MA26862A1 publication Critical patent/MA26862A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

De nouveaux esters dérivant de (RR,SS)-3 (2-diméthyl-aminornéthyl-1-hydroxycyclohexyl) phényle 2-hydi oxybenzoate, analogie au Tramadol, un procédé pour les obtenir et l'utilisation de ces composés pour la production d'un médicament ayant des propriétés analgésiques. Ces nouveaux produits de la formule générale (1) présentent une activité analgésique supérieure à celle de tramadol.
MA26710A 1999-12-30 2002-06-24 Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate MA26862A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000060A ES2160534B1 (es) 1999-12-30 1999-12-30 Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.

Publications (1)

Publication Number Publication Date
MA26862A1 true MA26862A1 (fr) 2004-12-20

Family

ID=8491916

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26710A MA26862A1 (fr) 1999-12-30 2002-06-24 Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate

Country Status (30)

Country Link
US (1) US6894076B2 (fr)
EP (1) EP1251120B1 (fr)
JP (1) JP2003519208A (fr)
KR (1) KR20020063281A (fr)
CN (1) CN1414946A (fr)
AP (1) AP1234A (fr)
AT (1) ATE284380T1 (fr)
AU (1) AU775918B2 (fr)
BG (1) BG106883A (fr)
BR (1) BR0016882A (fr)
CA (1) CA2395976A1 (fr)
CZ (1) CZ20022189A3 (fr)
DE (1) DE60016631D1 (fr)
EA (1) EA004770B1 (fr)
EE (1) EE200200365A (fr)
ES (1) ES2160534B1 (fr)
HR (1) HRP20020559A2 (fr)
HU (1) HUP0204147A3 (fr)
IL (1) IL150392A0 (fr)
IS (1) IS6440A (fr)
MA (1) MA26862A1 (fr)
MX (1) MXPA02006514A (fr)
NO (1) NO20023098D0 (fr)
NZ (1) NZ520263A (fr)
OA (1) OA12132A (fr)
PL (1) PL356056A1 (fr)
SK (1) SK9252002A3 (fr)
WO (1) WO2001049650A1 (fr)
YU (1) YU50902A (fr)
ZA (1) ZA200205193B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
AU2009207796B2 (en) 2008-01-25 2014-03-27 Grunenthal Gmbh Pharmaceutical dosage form
HRP20161307T1 (hr) 2008-05-09 2016-12-02 Grünenthal GmbH Postupak za pripravu praškaste formulacije međuproizvoda i konačni kruti oblik doziranja uz korištenje koraka zgrušavanja raspršivanjem
US8058469B2 (en) * 2008-11-03 2011-11-15 Sabic Innovative Plastics Ip B.V. Method for making carbamates, ureas and isocyanates
CA2765971C (fr) 2009-07-22 2017-08-22 Gruenenthal Gmbh Forme galenique extrudee a chaud a liberation controlee
PE20120631A1 (es) 2009-07-22 2012-06-06 Gruenenthal Chemie Forma de dosificacion resistente a la manipulacion para opioides sensibles a la oxidacion
EP2383255A1 (fr) 2010-04-28 2011-11-02 Lacer, S.A. Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
PL2611426T3 (pl) 2010-09-02 2014-09-30 Gruenenthal Gmbh Postać dawkowania zawierająca nieorganiczne sole, odporna na zgniatanie
AR082862A1 (es) 2010-09-02 2013-01-16 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico
EP2530072A1 (fr) 2011-06-03 2012-12-05 Lacer, S.A. Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
HRP20171458T1 (hr) 2011-07-29 2017-11-17 Grünenthal GmbH Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
KR20140053159A (ko) 2011-07-29 2014-05-07 그뤼넨탈 게엠베하 즉시 약물 방출을 제공하는 탬퍼-저항성 정제
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
PT2838512T (pt) 2012-04-18 2018-11-09 Gruenenthal Gmbh Forma farmacêutica resistente à adulteração e resistente à libertação inesperada de alta quantidade (dose-dumping)
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
EA032465B1 (ru) 2013-07-12 2019-05-31 Грюненталь Гмбх Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
HK1224189A1 (zh) 2013-11-26 2017-08-18 Grünenthal GmbH 通过低温研磨制备粉状药物组合物
EP3142646A1 (fr) 2014-05-12 2017-03-22 Grünenthal GmbH Formulation pour capsule à libération immédiate résistant aux manipulations illicites comprenant du tapentadol
HK1246173A1 (zh) 2015-04-24 2018-09-07 Grünenthal GmbH 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
WO2017042325A1 (fr) 2015-09-10 2017-03-16 Grünenthal GmbH Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus
US10442793B2 (en) 2015-10-15 2019-10-15 Jiangsu Hengrui Medicine Co., Ltd Oxa spiro derivative, preparation method therefor, and applications thereof in medicines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
DE1518663A1 (de) 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3562589A (en) * 1968-09-09 1971-02-09 Ite Imperial Corp Electrically resetting undervoltage trip for circuit breakers
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
GB9924604D0 (en) * 1999-10-18 1999-12-22 European Molecular Biology Lab Embl Genetic switch

Also Published As

Publication number Publication date
NZ520263A (en) 2004-07-30
KR20020063281A (ko) 2002-08-01
EE200200365A (et) 2003-10-15
HUP0204147A2 (hu) 2003-04-28
EP1251120B1 (fr) 2004-12-08
HUP0204147A3 (en) 2003-10-28
US6894076B2 (en) 2005-05-17
WO2001049650A1 (fr) 2001-07-12
NO20023098L (no) 2002-06-26
YU50902A (sh) 2006-01-16
EA004770B1 (ru) 2004-08-26
CZ20022189A3 (cs) 2003-03-12
ES2160534A1 (es) 2001-11-01
ZA200205193B (en) 2003-06-27
CN1414946A (zh) 2003-04-30
AU2012601A (en) 2001-07-16
CA2395976A1 (fr) 2001-07-12
JP2003519208A (ja) 2003-06-17
EA200200614A1 (ru) 2002-12-26
OA12132A (en) 2006-05-05
AP2002002571A0 (en) 2002-09-30
HRP20020559A2 (en) 2004-02-29
BR0016882A (pt) 2002-11-05
ATE284380T1 (de) 2004-12-15
PL356056A1 (en) 2004-06-14
US20030100598A1 (en) 2003-05-29
AU775918B2 (en) 2004-08-19
IL150392A0 (en) 2002-12-01
BG106883A (en) 2003-05-30
NO20023098D0 (no) 2002-06-26
SK9252002A3 (en) 2003-04-01
DE60016631D1 (de) 2005-01-13
MXPA02006514A (es) 2004-07-30
EP1251120A1 (fr) 2002-10-23
AP1234A (en) 2003-12-28
IS6440A (is) 2002-06-25
ES2160534B1 (es) 2002-04-16

Similar Documents

Publication Publication Date Title
MA26862A1 (fr) Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate
MA26765A1 (fr) Nouveaux esters derives de composes phenyl-cyclohexyl substitues.
EP1263721B1 (fr) Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation
CN101511350A (zh) 二氧代烷与二氧代烯
JP2020036617A (ja) カンナビノイド化合物を同時作製する装置及び方法
CA2206794A1 (fr) Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament
AU2003202585A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
HU215110B (hu) Eljárás szubsztituált taxánszármazékok és hatóanyagként ilyen vegyületeket tartalmazó gyógyszerkészítmények előállítására
WO2002042250B1 (fr) DERIVES DE L'ACIDE 4-HYDROXYBUTANOÏQUE ET DE SON HOMOLOGUE SUPERIEUR COMME LIGANDS DES RECEPTEURS DU η-HYDROXYBUTYRATE (GHB) COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET UTILISATIONS PHARMACEUTIQUES
CN1144878C (zh) 制备光学纯的(S)-3-羟基-γ-丁内酯的方法
Mikami et al. Asymmetric [2, 3] Wittig rearrangement involving chiral potassium azaenolates. The dramatic influence of the potassium counterion and its complexation with 18-crown-6
CA1213892A (fr) Procede de preparation de nouveaux derives de la sulfonyluree
CA2399819C (fr) Procede de separation enzymatique de racemates de derives d'aminomethyl-aryl-cyclohexanol
US5232941A (en) Caffeic acid derivatives and pharmaceutical compositions containing the same
KR101399551B1 (ko) 광학적으로 활성인 사이클로펜텐온의 제조방법 및 그로부터제조된 사이클로펜텐온
CA2337269C (fr) Nouveau procede de preparation d'intermediaires de synthese
CA1265803A (fr) Amides substitues, leur preparation et les medicaments qui les contiennent
KR19980703485A (ko) 에폭시숙신산 유도체
Senanayake et al. Rabbit liver esterase-mediated enantioselective synthesis of 2-arylpropanoic acids
KR100402048B1 (ko) 키랄 에스테르의 제조방법
Shi-Hui et al. Synthesis of enantiomerically pure cycloalkenols via combination strategy of enzyme-catalyzed reaction and RCM reaction
WO2005063671A1 (fr) Derives d'ether
CN1152026C (zh) 多环的2-氨基二氢噻唑体系、它们的制备方法和它们作为药物的用途
CN101462971B (zh) 高纯度的用于制备福莫特罗的关键中间体及其制备方法
EP2065371A1 (fr) Catalyseurs organiques chiraux pour la réduction stéréosélective de doubles liaisons carbone - azote pour la préparation d'amines énantiomériquement enrichies